Answers are grounded in this paper and cite their sources.
Thiazolidinone–sulfonamide hybrids emerged as promising anticancer and antitubercular agents, and their anticancer activity was confirmed by docking studies.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: